Abstract:CircRNAs influence disease progression by regulating ferroptosis in three main ways, acting as miRNA sponges, binding to RBP, or directly influencing ferroptosis related proteins to regulate ferroptosis. CircRNAs hold potential as biomarkers for disease diagnosis, therapy, and prognosis, and their modulation of ferroptosis through various mechanisms is likely to aid in disease treatment. Circular RNA (circRNA), classified as a type of non‐coding RNA, has gained significant attention in the field of biology due to its distinctive ring structure and functional properties. Recent research has provided evidence that specific circRNAs have the ability to modulate disease progression through diverse mechanisms, one of which is by regulating cellular ferroptosis. Ferroptosis is a form of regulated cell death that is driven by iron dependency and lipid peroxidation, and extensive investigations have revealed a relationship between ferroptosis and disease development. In addition to evidence that both circRNAs and ferroptosis exert critical roles in disease progression, circRNAs have also been shown to actively mediate the process of ferroptosis. The relationship between circRNAs and ferroptosis therefore influences disease progression and offers novel targets for disease treatment. By directly or indirectly modulating the expression of circRNAs that regulate the expression of ferroptosis‐related proteins, it may be possible to impact disease progression by promoting or inhibiting ferroptosis. Current research indicates such approaches may hold significant value in a wide variety of common diseases across physiological systems. This review comprehensively summarizes the findings of recent studies investigating the roles of circRNAs in the regulation of ferroptosis in various diseases.

Emerging role of ferroptosis-related circular RNA in tumor metastasis

Emerging roles of ferroptosis-related miRNAs in tumor metastasis

Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer

Ferroptosis in Cancer Progression: Role of Noncoding RNAs

Circular RNAs in ferroptosis: regulation mechanism and potential clinical application in disease

Research status and potential applications of circRNAs affecting colorectal cancer by regulating ferroptosis

Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Iron Metabolism, Ferroptosis, and Lncrna in Cancer: Knowns and Unknowns

Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs

CircRNA and ferroptosis in human disease: Insights for new treatments

The role of non-coding RNAs in ferroptosis regulation

Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response

Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma

Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical implications

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects

Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer